Performance Comparison of Microfluidic and Immunomagnetic Platforms for Pancreatic CTC Enrichment
November 15, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Arilex,Betacerin, Cartishine
Synonyms :
diacerein
Class :
Anti-inflammatory Agent; Analgesic, Nonopioid
Brand Name :
Arilex,Betacerin, Cartishine
Synonyms :
diacerein
Class :
Anti-inflammatory Agent; Analgesic, Nonopioid
Dosage Forms & StrengthsÂ
CapsuleÂ
25mgÂ
50mgÂ
Administer 50 to 100mg orally in one to two divided doses daily.
Safety and efficacy not established.Â
Refer adult dosingÂ
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may increase the serum concentration
may enhance serum concentrations when combined with tetrabenazine
may enhance the serum concentration when combined with fenfluramine
may enhance the serum concentration when combined with fenfluramine
may diminish the serum concentration when combined with CYP2D6 substrates
may enhance the serum concentration
may increase the serum concentration of Rasagiline
may enhance the concentration of serum when combined with theophylline derivatives
may enhance the concentration of serum when combined with thioridazine
pirfenidone: they may enhance the serum concentration of CYP1A2 Inhibitors
pomalidomide: they may enhance the serum concentration of CYP1A2 Inhibitors
propranolol: they may enhance the serum concentration of CYP1A2 Inhibitors
arginine: they may enhance the serum concentration of CYP2D6 Inhibitors
nicardipine: they may enhance the serum concentration of CYP2D6 Inhibitors
brimonidine: they may enhance the serum concentration of CYP2D6 Inhibitors
cimetidine: they may enhance the serum concentration of CYP2D6 Inhibitors
clopidogrel: they may enhance the serum concentration of CYP2D6 Inhibitors
dapoxetine: they may enhance the serum concentration of CYP2D6 Inhibitors
diazoxide: they may enhance the serum concentration of CYP2D6 Inhibitors
eluxadoline: they may increase the CNS depressant effect of CNS Depressants
aripiprazole lauroxil: they may enhance the serum concentration of CYP2D6 Inhibitors
brexpiprazole: they may enhance the serum concentration of CYP2D6 Inhibitors
lemborexant: they may enhance the serum concentration of CYP2D6 Inhibitors
pitolisant: they may enhance the serum concentration of CYP2D6 Inhibitors
ubrogepant: they may enhance the serum concentration of CYP2D6 Inhibitors
caplacizumab: they may enhance the serum concentration of CYP2D6 Inhibitors
cilostazol: they may enhance the serum concentration of CYP2D6 Inhibitors
eliglustat: they may enhance the serum concentration of CYP2D6 Inhibitors
dextroamphetamine: they may enhance the serum concentration of CYP2D6 Inhibitors
enoxaparin: they may enhance the serum concentration of CYP2D6 Inhibitors
gilteritinib: they may enhance the serum concentration of CYP2D6 Inhibitors
fluoxetine: they may enhance the serum concentration of CYP2D6 Inhibitors
oxycodone: they may enhance the serum concentration of CYP2D6 Inhibitors
lomitamide: they may enhance the serum concentration of CYP2D6 Inhibitors
safinamide: they may enhance the serum concentration of CYP2D6 Inhibitors
inhibitors of the cytochrome P450 enzyme system, like ketoconazole and clarithromycin, have the potential to enhance the exposure and toxicity of rimonabant since it undergoes liver metabolism mediated by this enzyme system
apixaban: it may enhance the toxic effect of Anti-Inflammatory Agents
enoxaparin: it may enhance the toxic effect of Anti-Inflammatory Agents
heparin: it may enhance the toxic effect of Anti-Inflammatory Agents
abrocitinib: it may enhance the toxic effect of Anti-Inflammatory Agents
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
CYP2D6 inhibitors increase the concentration of aripiprazole in the serum
they increase the concentration of alosetron in the serum
they decrease the concentration of active metabolites of iloperidone in the serum
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may enhance the serum concentration when combined
may diminish the concentration of serum when combined with CYP1A2 substrates
agomelatine: they may enhance the serum concentration of CYP1A2 Inhibitors
duloxetine: they may enhance the serum concentration of CYP1A2 Inhibitors
melatonin: they may enhance the serum concentration of CYP1A2 Inhibitors
mexiletine: they may enhance the serum concentration of CYP1A2 Inhibitors
ramelteon: they may enhance the serum concentration of CYP1A2 Inhibitors
tasimelteon: they may enhance the serum concentration of CYP1A2 Inhibitors
may increase the serum concentration of each other when combined
sincalide: they may enhance the serum concentration of CYP2D6 Inhibitors
obinutuzumab: they may enhance the serum concentration of CYP2D6 Inhibitors
doxorubicin: they may enhance the serum concentration of CYP2D6 Inhibitors
pimozide: they may enhance the serum concentration of CYP2D6 Inhibitors
aclidinium: they may enhance the serum concentration of CYP2D6 Inhibitors
bromopride: they may enhance the serum concentration of CYP2D6 Inhibitors
cimetropium: they may enhance the serum concentration of CYP2D6 Inhibitors
glycopyrrolate: they may enhance the serum concentration of CYP2D6 Inhibitors
ipratropium: they may enhance the serum concentration of CYP2D6 Inhibitors
levosulpiride: they may enhance the serum concentration of CYP2D6 Inhibitors
mavacamten: they may enhance the serum concentration of CYP2D6 Inhibitors
olopatadine: they may enhance the serum concentration of CYP2D6 Inhibitors
rasagiline: they may enhance the serum concentration of CYP2D6 Inhibitors
selegiline: they may enhance the serum concentration of CYP2D6 Inhibitors
Diacerein may increase the therapeutic effect of Diuretics
Diacerein may increase the therapeutic effect of Diuretics
Diacerein may increase the therapeutic effect of Diuretics
Diacerein may increase the therapeutic effect of Diuretics
Diacerein may increase the therapeutic effect of Diuretics
antacids reduces the systemic absorption of diacerein
antacids reduces the systemic absorption of diacerein
antacids reduces the systemic absorption of diacerein
antacids reduces the systemic absorption of diacerein
antacids reduces the systemic absorption of diacerein
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration of amphetamines
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the serum concentration
may increase the serum concentration
bazedoxifene/conjugated estrogens
may increase the serum concentration
synthetic conjugated estrogens, a
may increase the serum concentration
synthetic conjugated estrogens, b
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the QTc-prolonging effect
may increase the QTc-prolonging effect
may increase the QTc-prolonging effect
may increase the QTc-prolonging effect
may increase the QTc-prolonging effect
may increase the levels of serum concentrations
may increase the levels of serum concentrations
may increase the levels of serum concentrations
may increase the levels of serum concentrations
may increase the levels of serum concentrations
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
acetaminophen and phenyltoloxamine
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
acetaminophen and phenyltoloxamine
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
antacids can reduce the absorption of diacerein
antacids can reduce the absorption of diacerein
antacids can reduce the absorption of diacerein
antacids can reduce the absorption of diacerein
antacids can reduce the absorption of diacerein
it may increase the levels of serum concentration
it may increase the levels of serum concentration
may reduce the levels of serum concentration
may reduce the levels of serum concentration
may reduce the levels of serum concentration
may reduce the levels of serum concentration
spironolactone and hydrochlorothiazide
diacerein: they may increase the therapeutic effect when combined with diuretics
diacerein: they may increase the therapeutic effect when combined with diuretics
diacerein: they may increase the therapeutic effect when combined with diuretics
diacerein: they may increase the therapeutic effect when combined with diuretics
diacerein: they may increase the therapeutic effect when combined with diuretics
it may diminish the metabolism when combined with ciclesonide
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
when bromazepam and diacerein are used together, there is a potential reduction in the bromazepam's metabolism
Combining tegafur with diacerein can reduce tegafur’s metabolism
When acetohexamide is used together with diacerein, this lead to reduction in acetohexamide’s metabolism
When encainide is used together with diacerein, this leads to a reduction in the encainide’s metabolism
diacerein: they may increase the CNS depressant effect of CNS Depressants
diacerein: they may increase the CNS depressant effect of CNS Depressants
diacerein: they may increase the CNS depressant effect of CNS Depressants
diacerein: they may increase the CNS depressant effect of CNS Depressants
diacerein: they may increase the CNS depressant effect of CNS Depressants
may enhance the serum concentration
may enhance the serum concentration
may enhance the serum concentration
may enhance the serum concentration
may enhance the serum concentration
systemic beta blockade is shown when CYP2D6 inhibtors are combined in use with antiglaucoma agents
may enhance the serum concentration when combined with propranolol
may enhance the serum concentration when combined with propranolol
may enhance the serum concentration when combined with propranolol
may enhance the serum concentration when combined with propranolol
may enhance the serum concentration when combined with propranolol
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may enhance the serum concentration
may enhance the serum concentration
may decrease the level of serum concentration of pretomanid
may increase the serum concentration
may increase the serum concentration of amphetamines
may enhance the serum concentration when combined with CYP2D6 substrates
may enhance the serum concentrations of CYP2D6 inhibitors
may diminish the serum concentration of Lidocaine
promethazine/dextromethorphanÂ
may increase the serum concentration of Dextromethorphan
may increase the levels of serum concentration
may enhance the concentration of serum when combined with timolol
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
bazedoxifene/conjugated estrogens
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
clozapine: they may enhance the serum concentration of CYP1A2 Inhibitors
may enhance the concentration of serum when combined with asenapine
acetaminophen/doxylamine/dextromethorphanÂ
may enhance the serum concentration when combined
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
may increase the levels of serum concentration
anagrelide: they may enhance serum concentrations of CYP1A2 Inhibitors
bromazepam: they may enhance the serum concentration of CYP1A2 Inhibitors
clomipramine: they may enhance the serum concentration of CYP1A2 Inhibitors
levobupivacaine: they may enhance the serum concentration of CYP1A2 Inhibitors
lidocaine: they may enhance the serum concentration of CYP1A2 Inhibitors
olanzapine: they may enhance the serum concentration of CYP1A2 Inhibitors
pentoxifylline: they may enhance the serum concentration of CYP1A2 Inhibitors
ramosetron: they may enhance the serum concentration of CYP1A2 Inhibitors
riluzole: they may enhance the serum concentration of CYP1A2 Inhibitors
ropinirole: they may enhance the serum concentration of CYP1A2 Inhibitors
ropivacaine: they may enhance the serum concentration of CYP1A2 Inhibitors
CYP2D6 Inhibitors: they may enhance the serum concentration of nebivolol
may decrease the serum concentration when combined with CYP1A2 substrates
may decrease the serum concentration when combined with CYP1A2 substrates
It may enhance the risk of adverse effects when combined with CYP1A2 inhibitors
It may enhance the risk of adverse effects when combined with CYP1A2 inhibitors
It may enhance the risk of adverse effects when combined with CYP1A2 inhibitors
amitriptyline: they may enhance the serum concentration of CYP2D6 Inhibitors
amoxapine: they may enhance the serum concentration of CYP2D6 Inhibitors
amphetamine: they may enhance the serum concentration of CYP2D6 Inhibitors
atomoxetine: they may enhance the serum concentration of CYP2D6 Inhibitors
bupropion: they may enhance the serum concentration of CYP2D6 Inhibitors
carvedilol: they may enhance the serum concentration of CYP2D6 Inhibitors
celiprolol: they may enhance the serum concentration of CYP2D6 Inhibitors
clomipramine: they may enhance the serum concentration of CYP2D6 Inhibitors
clozapine: they may enhance the serum concentration of CYP2D6 Inhibitors
codeine: they may enhance the serum concentration of CYP2D6 Inhibitors
rolapitant: they may enhance the serum concentration of CYP2D6 Inhibitors
desipramine: they may enhance the serum concentration of CYP2D6 Inhibitors
deutetrabenazine: they may enhance the serum concentration of CYP2D6 Inhibitors
doxepin: they may enhance the serum concentration of CYP2D6 Inhibitors
flecainide: they may enhance the serum concentration of CYP2D6 Inhibitors
imipramine: they may enhance the serum concentration of CYP2D6 Inhibitors
oliceridine: they may enhance the serum concentration of CYP2D6 Inhibitors
propafenone: they may enhance the serum concentration of CYP2D6 Inhibitors
propranolol: they may enhance the serum concentration of CYP2D6 Inhibitors
protriptyline: they may enhance the serum concentration of CYP2D6 Inhibitors
tamsulosin: they may enhance the serum concentration of CYP2D6 Inhibitors
tramadol: they may enhance the serum concentration of CYP2D6 Inhibitors
valbenazine: they may enhance the serum concentration of CYP2D6 Inhibitors
vortioxetine: they may enhance the serum concentration of CYP2D6 Inhibitors
zuclopenthixol: they may enhance the serum concentration of CYP2D6 Inhibitors
amifostine: they may enhance the serum concentration of CYP2D6 Inhibitors
flunarizine: they may enhance the serum concentration of CYP2D6 Inhibitors
melatonin: they may enhance the serum concentration of CYP2D6 Inhibitors
molsidomine: they may enhance the serum concentration of CYP2D6 Inhibitors
dimercaprol: they may enhance the serum concentration of CYP2D6 Inhibitors
levonorgestrel: they may enhance the serum concentration of CYP2D6 Inhibitors
quinidine: they may enhance the serum concentration of CYP2D6 Inhibitors
butchers broom: they may enhance the serum concentration of CYP2D6 Inhibitors
finerenone: they may enhance the serum concentration of CYP2D6 Inhibitors
alprazolam: they may enhance the serum concentration of CYP2D6 Inhibitors
ephedrine: they may enhance the serum concentration of CYP2D6 Inhibitors
kaolin: they may enhance the serum concentration of CYP2D6 Inhibitors
verteporfin: they may enhance the serum concentration of CYP2D6 Inhibitors
trimipramine: they may enhance the serum concentration of CYP2D6 Inhibitors
vitamin K1: they may enhance the serum concentration of CYP2D6 Inhibitors
triazolam: they may enhance the serum concentration of CYP2D6 Inhibitors
alvimopan: they may enhance the serum concentration of CYP2D6 Inhibitors
chlormethiazole: they may enhance the serum concentration of CYP2D6 Inhibitors
flunitrazepam: they may enhance the serum concentration of CYP2D6 Inhibitors
nalmefene: they may enhance the serum concentration of CYP2D6 Inhibitors
suvorexant: they may enhance the serum concentration of CYP2D6 Inhibitors
zolpidem: they may enhance the serum concentration of CYP2D6 Inhibitors
opioid drugs: they may enhance the serum concentration of CYP2D6 Inhibitors
opioid drugs: they may enhance the serum concentration of CYP2D6 Inhibitors
opioid drugs: they may enhance the serum concentration of CYP2D6 Inhibitors
opioid drugs: they may enhance the serum concentration of CYP2D6 Inhibitors
samidorphan: they may enhance the serum concentration of CYP2D6 Inhibitors
naltrexone: they may enhance the serum concentration of CYP2D6 Inhibitors
monoamine oxidase inhibitor: they may enhance the serum concentration of CYP2D6 Inhibitors
monoamine oxidase inhibitor: they may enhance the serum concentration of CYP2D6 Inhibitors
monoamine oxidase inhibitor: they may enhance the serum concentration of CYP2D6 Inhibitors
monoamine oxidase inhibitor: they may enhance the serum concentration of CYP2D6 Inhibitors
monoamine oxidase inhibitor: they may enhance the serum concentration of CYP2D6 Inhibitors
thalidomide: they may enhance the serum concentration of CYP2D6 Inhibitors
alizapride: they may enhance the serum concentration of CYP2D6 Inhibitors
kava: they may enhance the serum concentration of CYP2D6 Inhibitors
metyrosine: they may enhance the serum concentration of CYP2D6 Inhibitors
piribedil: they may enhance the serum concentration of CYP2D6 Inhibitors
anagrelide: they may enhance the serum concentration of CYP2D6 Inhibitors
belzutifan: they may enhance the serum concentration of CYP2D6 Inhibitors
cannabis: they may enhance the serum concentration of CYP2D6 Inhibitors
dasatinib: they may enhance the serum concentration of CYP2D6 Inhibitors
etravirine: they may enhance the serum concentration of CYP2D6 Inhibitors
inotersen: they may enhance the serum concentration of CYP2D6 Inhibitors
lithium: they may enhance the serum concentration of CYP2D6 Inhibitors
metoprolol: they may enhance the serum concentration of CYP2D6 Inhibitors
nifedipine: they may enhance the serum concentration of CYP2D6 Inhibitors
omeprazole: they may enhance the serum concentration of CYP2D6 Inhibitors
perampanel: they may enhance the serum concentration of CYP2D6 Inhibitors
quetiapine: they may enhance the serum concentration of CYP2D6 Inhibitors
ramosetron: they may enhance the serum concentration of CYP2D6 Inhibitors
quinagolide: they may enhance the serum concentration of CYP2D6 Inhibitors
methotrexate: it may enhance the toxic effect of Anti-Inflammatory Agents
pralatrexate: it may enhance the toxic effect of Anti-Inflammatory Agents
rivaroxaban: it may enhance the toxic effect of Anti-Inflammatory Agents
sincalide: it may enhance the toxic effect of Anti-Inflammatory Agents
acemetacin: it may enhance the toxic effect of Anti-Inflammatory Agents
ketorolac: it may enhance the toxic effect of Anti-Inflammatory Agents
macimorelin: it may enhance the toxic effect of Anti-Inflammatory Agents
phenylbutazone: it may enhance the toxic effect of Anti-Inflammatory Agents
urokinase: it may enhance the toxic effect of Anti-Inflammatory Agents
vancomycin: it may enhance the toxic effect of Anti-Inflammatory Agents
acalabrutinib: it may enhance the toxic effect of Anti-Inflammatory Agents
cephalothin: it may enhance the toxic effect of Anti-Inflammatory Agents
dasatinib: it may enhance the toxic effect of Anti-Inflammatory Agents
deferasirox: it may enhance the toxic effect of Anti-Inflammatory Agents
When diacerein is used together with oliceridine, this leads to reduction in oliceridine’s metabolism
induction of these enzymes is shown by bupleurum at high doses
When diacerein is aided by hesperetin, it reduces hesperetin’s metabolism
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
they increase the concentration of metoclopramide in the serum
they decrease the concentration of active metabolites of tamoxifen in serum
Actions and Spectrum:Â
diacerein’s primary mechanism of action involves its effects on the inflammatory processes and cartilage metabolism within joints:Â
diacerein’s spectrum of activity is primarily focused on osteoarthritis:Â
Frequency not definedÂ
Stomach discomfort and painÂ
VomitingÂ
Urine discolorationÂ
DiarrheaÂ
NauseaÂ
Yellowing of eyes and skinÂ
Black box warning:Â
NoneÂ
Contraindications/caution:Â
Contraindications:Â
Caution:Â
Pregnancy consideration: diacerein is generally contraindicated during pregnancy due to concerns about potential effects on the developing fetus.Â
Lactation: It is also not recommended during breastfeeding, as the effects on the nursing infant are not well established.Â
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Pharmacology:Â
diacerein’s mechanism of action is multifaceted and involves several key aspects:Â
Pharmacokinetics:Â
AbsorptionÂ
diacerein is absorbed from the gastrointestinal tract after oral administration. It undergoes biotransformation in the liver to its active metabolite, rhein.Â
DistributionÂ
The active metabolite, rhein, is distributed throughout the body, including joint tissues.Â
MetabolismÂ
diacerein is metabolized into rhein through glucuronidation in the liver. Rhein is the compound responsible for the majority of diacerein’s therapeutic effects.Â
Elimination and ExcretionÂ
Both diacerein and its active metabolite, rhein, are excreted mainly through the urine. The elimination half-life of diacerein is relatively short, while rhein’s half-life is more prolonged.Â
Administration:Â
Oral administrationÂ
diacerein is typically taken orally with water, and it is recommended to take it with a meal to help minimize gastrointestinal side effects. Taking it with food can also enhance its absorption.Â
Patient information leafletÂ
Generic Name: diacerein Â
Why do we use diacerein?Â
diacerein is primarily used for the treatment of osteoarthritis. It has anti-inflammatory and potential disease-modifying effects on joint structures. Here are the common uses of diacerein:Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
